Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2011
11/24/2011WO2011117396A3 Thermostable phytase variants
11/24/2011WO2011107483A3 Enzyme aspartokinase iii having a reduced l-lysine feedback inhibition
11/24/2011WO2011101811A3 Improved meganuclease recombination system
11/24/2011WO2011095958A3 Improvement of the grain filling of a plant through the modulation of nadh-glutamate synthase activity
11/24/2011WO2011066282A3 Methods and compositions for treating oxalate-related conditions
11/24/2011WO2011053998A3 Targeting of modifying enzymes for protein evolution
11/24/2011WO2011038244A3 Methylketone synthase, production of methylketones in plants and bacteria
11/24/2011US20110289632 Methylketone synthase, production of methylketones in plants and bacteria
11/24/2011US20110289628 Polyunsaturated fatty acid elongase
11/24/2011US20110289622 Expression cassettes for transgenic expression of nucleic acids
11/24/2011US20110288286 Process for the enzymatic production of cyclic diguanosine monophosphate employing a diguanylate cyclase comprising a mutated rxxd motif
11/24/2011US20110288284 Methods and compositions for isolating polynucleotides
11/24/2011US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011US20110288176 Ethacrynic acid-containing composition for prevention or treatment of transglutaminase-related diseases and method for prevention or treatment of transglutaminase-related diseases using the same
11/24/2011US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases
11/24/2011US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
11/24/2011US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses
11/24/2011US20110287950 Protein fragment complementation assays for the detection of biological or drug interactions
11/24/2011US20110287518 Polypeptide Purification
11/24/2011US20110287517 Degradable Clostridial Toxins
11/24/2011US20110287516 Alpha-Amylase Variants
11/24/2011US20110287515 Protein and dna sequence encoding a cold adapted xylanase
11/24/2011US20110287514 Cytotoxic ribonuclease variants
11/24/2011US20110287513 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/24/2011US20110287512 Compositions for linking zinc finger modules
11/24/2011US20110287511 Novel Trichoderma Genes
11/24/2011US20110287510 Methods and kits for reducing non-specific nucleic acid amplification
11/24/2011US20110287506 Genetically modified yeast species, and fermentation processes using genetically modified yeast
11/24/2011US20110287505 Genetically modified yeast species, and fermentation processes using genetically modified yeast
11/24/2011US20110287494 Process for production of optically active amine derivative
11/24/2011US20110287489 Recombinational cloning using engineered recombination sites
11/24/2011US20110287488 Novel n-acetylglucosamine-2-epimerase and method for producing cmp-neuraminic acid using the same
11/24/2011US20110287484 Expression vector containing the major envelope protein p9 of cystovirus phi6 as a fusion partner, and process for producing a membrane protein using the same
11/24/2011US20110287467 Methods of producing recombinant heme-binding proteins and uses thereof
11/24/2011US20110287466 Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
11/24/2011US20110287451 Novel anti cxcr4 antibodies and their use for the treatment of cancer
11/24/2011US20110287445 Mutant ROS Expression In Human Cancer
11/24/2011US20110287442 Tumor Antigen Protein, Gene, or Peptides from Topoisimerase 2 Alpha
11/24/2011US20110287440 Composition and method for reconstituting IkB kinase in yeast and method of using same
11/24/2011US20110287435 Transposon end compositions and methods for modifying nucleic acids
11/24/2011US20110287142 Creation of diversity in polypeptides
11/24/2011US20110287141 Cloning, expression and use of acid phospholipases
11/24/2011US20110287137 Method of producing non-bovine chymosin and use hereof
11/24/2011US20110287135 Novel arabinohydrolases
11/24/2011US20110287084 Method for reducing body fat and increasing lean body mass by reducing stearoyl-coa desaturase 1 activity
11/24/2011US20110287041 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
11/24/2011US20110287031 Covalently reactive transition state analogs and methods of use thereof
11/24/2011US20110287016 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
11/24/2011US20110286991 Peptides derived from hmg-coa reductase and cosmetic and/or pharmaceutical composition containing same
11/24/2011US20110286989 ANGIOGENIN COMPLEXES (ANGex) WITH LIPID-BASED SUBSTRATES AND USES THEREOF
11/24/2011US20110286988 FVIII Muteins for Treatment of Von Willebrand Disease
11/24/2011US20110286984 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
11/24/2011US20110286977 G6PC2-Encoded Beta Cell Surface Tags
11/24/2011US20110286969 Deuterated compounds as hepatitis c virus (hcv) inhibitors
11/24/2011US20110286956 Novel multi-arm polyethylene glycol, preparation method and uses thereof
11/24/2011US20110286952 Dermocosmetic composition, aesthetic treatment method using the composition, and use of the composition for lightening the pigmentation of the skin
11/24/2011US20110286916 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
11/24/2011CA2799559A1 Production of dha and other lc-pufas in plants
11/24/2011CA2798988A1 Novel dna-binding proteins and uses thereof
11/23/2011EP2388333A2 A method of producing a low molecular weight organic compound in a cell
11/23/2011EP2388332A1 Process for the production of delta5-unsaturated fatty acids in transgenic organisms
11/23/2011EP2388322A1 Enzymatic preparation containing thermostable dna polymerase, process for producing same, and method for detecting analyte organism
11/23/2011EP2388321A1 Novel expression vector
11/23/2011EP2388317A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
11/23/2011EP2388316A2 Aldolases, nucleic acids encoding them and methods for making and using them
11/23/2011EP2388267A1 Alpha-amylase mutants
11/23/2011EP1836223B1 Method for identifying a nucleic acid encoding a hemopexin-like structure which specifically binds a predetermined target molecule.
11/23/2011EP1817411B1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
11/23/2011EP1773997B1 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
11/23/2011EP1735439B1 Cleavage of vegf and vegf receptor by wildtype and mutant mt-sp1
11/23/2011EP1592786B1 Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge)
11/23/2011EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011EP1471443B1 Method of constructing stereostructure of protein having plural number of chains
11/23/2011EP1390482B1 Compositions and methods for random nucleic acid mutagenisis
11/23/2011EP1349576B1 Combined use of enzyme inhibitors for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with follicular and epidermal hyperkeratosis and reinforced keratinocyte proliferation
11/23/2011EP1297109B1 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
11/23/2011EP0932688B1 Chrysosporium cellulase and methods of use
11/23/2011CN1898563B Method of diagnosing breast cancer
11/23/2011CN1618801B D-aminoacylase mutants
11/23/2011CN102257152A Microorganism for producing succinic acid
11/23/2011CN102257146A Method for speeding up plant growth and improving yield by introducing phosphatases in transgenic plant
11/23/2011CN102257139A Process for producing protein capable of forming inclusion body
11/23/2011CN102257137A Method for production of belta-glucanase and xylanase, and liquid culture medium
11/23/2011CN102257136A Chimeric DNA polymerases
11/23/2011CN102257128A Synthesis of fucosylated compounds
11/23/2011CN102257126A Reducing byproduction of malonates in a fermentation process
11/23/2011CN102256497A Stabilization of asparaginase
11/23/2011CN102251000A Preparation method of compound bioactive peptide
11/23/2011CN102250934A High-efficient expression and application of amidohydrolase
11/23/2011CN102250933A Method for expressing Reteplase in Escherichia coli by using dual plasmid system
11/23/2011CN102250931A Gene for coding beta-cyclodextrin glucosyltransferase and application thereof
11/23/2011CN102250930A Silkworm ecdysone oxidase EO gene
11/23/2011CN102250929A 3-locus dehydrogenated molting hormone alpha reductase 3DE-3alpha-reductase gene of bombyx mori
11/23/2011CN102250928A Delta-6 fatty acid dehydrogenase mutant gene and expression carrier and application thereof
11/23/2011CN102250926A Gene with function of glutamine synthelase, and encoded protein and cloning method thereof
11/23/2011CN102250925A Glutamine synthetase gene, protein coded by same and cloning method therefore
11/23/2011CN102250864A Dual purposes of linoleate isomerase in aspects of dehydrogenation and isomerism
11/23/2011CN102250863A Gene recombination human neutraphil elastase (HNE), preparation method thereof and medicinal usage of same
11/23/2011CN102250862A Method for producing chymosin by aspergillus niger solid fermentation